British Journal of Haematology

Liposomal cytarabine in cerebrospinal fluid
pp. 679-679(1)
Authors: Boyd, Kevin; Jenner, Matthew; Treleaven, Jennie; Kenny, Jackie; Rhoades, Elaine

Unexpected glucose-6-phosphate dehydrogenase deficiency
pp. 680-680(1)
Authors: Au, Wing-Yan; Tse, Jovic; So, Jason C. C.; Wan, Thomas S. K.; Young, Karl

Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
pp. 681-708(28)
Authors: Lonial, Sagar; Cavenagh, Jamie

Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
pp. 709-727(19)
Authors: Chapel, Helen; Cunningham-Rundles, Charlotte

Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis - a personal view
pp. 728-732(5)
Author: Schilling, Robert F.

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
pp. 733-740(8)
Authors: Else, Monica; Dearden, Claire E.; Matutes, Estella; Garcia-Talavera, Juan; Rohatiner, Ama Z. S.; Johnson, Steve A. N.; O'Connor, Nigel T. J.; Haynes, Andy; Osuji, Nnenna; Forconi, Francesco; Lauria, Francesco; Catovsky, Daniel

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas
pp. 741-748(8)
Authors: Brown, Jennifer R.; Friedberg, Jonathan W.; Feng, Yang; Scofield, Sarah; Phillips, Kimberly; Dal Cin, Paola; Joyce, Robin; Takvorian, Ronald W.; Fisher, David C.; Fisher, Richard I.; Liesveld, Jane; Marquis, Diana; Neuberg, Donna; Freedman, Arnold S.

Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study
pp. 749-760(12)
Authors: Ingram, Wendy; Chan, Lucas; Guven, Hayrettin; Darling, David; Kordasti, Shahram; Hardwick, Nicola; Barber, Linda; Mufti, Ghulam J.; Farzaneh, Farzin

The protein kinase C agonist PEP005 increases NF-κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
pp. 761-774(14)
Authors: Olsnes, Astrid Marta; Ersvær, Elisabeth; Ryningen, Anita; Paulsen, Kristin; Hampson, Peter; Lord, Janet M.; Gjertsen, Bjørn Tore; Kristoffersen, Einar Klæboe; Bruserud, Øystein

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease
pp. 775-787(13)
Authors: Pennisi, Angela; Li, Xin; Ling, Wen; Khan, Sharmin; Gaddy, Dana; Suva, Larry J.; Barlogie, Bart; Shaughnessy, John D.; Aziz, Nazneen; Yaccoby, Shmuel

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
pp. 788-800(13)
Authors: Gelsi-Boyer, Véronique; Trouplin, Virginie; Adélaïde, José; Bonansea, Julien; Cervera, Nathalie; Carbuccia, Nadine; Lagarde, Arnaud; Prebet, Thomas; Nezri, Meyer; Sainty, Danielle; Olschwang, Sylviane; Xerri, Luc; Chaffanet, Max; Mozziconacci, Marie-Joëlle; Vey, Norbert; Birnbaum, Daniel

Beta₂-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
pp. 801-805(5)
Authors: Delgado, Julio; Pratt, Guy; Phillips, Neil; Briones, Javier; Fegan, Chris; Nomdedeu, Josep; Pepper, Chris; Aventin, Anna; Ayats, Ramon; Brunet, Salut; Martino, Rodrigo; Valcarcel, David; Milligan, Donald; Sierra, Jorge

Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing
pp. 806-815(10)
Authors: Rujkijyanont, Piya; Adams, Sally-Lin; Beyene, Joseph; Dror, Yigal

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
pp. 816-824(9)
Authors: Ratanatharathorn, Voravit; Logan, Brent; Wang, Dan; Horowitz, Mary; Uberti, Joseph P.; Ringden, Olle; Gale, Robert Peter; Khoury, Hanna; Arora, Mukta; Spellman, Stephen; Cutler, Corey; Antin, Joseph; Bornhaüser, Martin; Hale, Gregory; Verdonck, Leo; Cairo, Mitchell; Gupta, Vikas; Pavletic, Steven

A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study
pp. 825-835(11)
Authors: Dargaud, Yesim; Rugeri, Lucia; Vergnes, Marie Christine; Arnuti, Brigitte; Miranda, Paula; Negrier, Claude; Bestion, Audrey; Desmurs-Clavel, Hélène; Ninet, Jacques; Gaucherand, Pascal; Rudigoz, Rene Charles; Berland, Michel; Champion, Fabienne; Trzeciak, Marie Christine

VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications
pp. 836-838(3)
Authors: Torres, Luis Arístides; Barbarroja, Nuria; Dorado, Gabriel; Velasco, Francisco; López-Pedrera, Chary

Is `Virchow's triad' useful?
pp. 839-839(1)
Authors: Malone, Padraic Colm; Agutter, Paul S.

Is `Virchow's triad' useful? - response to Malone and Agutter
pp. 840-841(2)
Authors: Bagot, Catherine N.; Arya, Roopen

A new VKORC1 mutation leading to an isolated resistance to fluindione
pp. 841-843(3)
Authors: Peoc'h, Katell; Pruvot, Sandrine; Gourmel, Céline; dit Sollier, Claire Bal; Drouet, Ludovic

Hb Southern Italy: coexistence of two missence mutations (the Hb Sun Prairie α2 130 Ala > Pro and Hb Caserta α2 26 Ala > Thr) in a single HBA2 gene
pp. 843-844(2)
Authors: Lacerra, Giuseppina; Carestia, Clementina